TRAW - Traws Pharma Inc logo

Traws Pharma Inc

TRAW
โš•๏ธ Healthcare NASDAQ Listed 2001 $ USD
$1,000 invested 10 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth-280.87%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-97.96%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.2
Net Growth-2.62%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-74.78%
Rev Trend20%
Revenue Consistencyโ€”
10 Years
Score
Net Growth15.67%
Net Trend40%
Net Income Consistency
Rev Growth-98.97%
Rev Trend30%
Revenue Consistency
All Time
Score
Net Growth45.29%
Net Trend47%
Net Income Consistency
Rev Growth-96.17%
Rev Trend33%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Traws Pharma Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. TRAW does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 0.34โ€”
1 Year2025-10-23
$ 2.63-86.98%
5 Years2021-10-22
$ 86.50-99.60%
10 Years2016-10-21
$ 14.57K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 57K-$ 16M
2025$ 2M$ 9M$ 3M
2024$ 226K-$ 54M$ 21M
2023$ 226K-$ 18M$ 20M
2022$ 226K-$ 18M$ 38M
2021$ 226K-$ 16M$ 55M
2020$ 231K-$ 25M$ 19M
2019$ 2M-$ 21M$ 22M
2018$ 1M-$ 20M$ 16M
2017$ 787K-$ 24M$ 4M
2016$ 5M-$ 19M$ 21M
2015$ 11M-$ 23M$ 19M
2014$ 800K-$ 63M$ 43M
2013$ 4M-$ 64M$ 100M
2012$ 46M-$ 33M$ 81M
2011$ 1M-$ 30M$ 2M
TRAW - Traws Pharma Inc logo

Traws Pharma Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 231K to $ 2M and net income went from -$ 25M to $ 9M. Revenue increased in 1 of those 5 years; net income in 2.

Across Traws Pharma Inc's full reported history, from 2011 to 2025, revenue grew from $ 1M to $ 2M and net income went from -$ 30M to $ 9M. Revenue increased in 33% of the years measured; net income in 47%.

Traws Pharma Inc currently holds a 5-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Membership

Explore TRAW with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies